phase readout
saveNCT06160791: Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
RECRUITINGupdated 17h ago
community read0 votes
Sponsor: Jerry Lee, MD, MSc, MPhil. Phase: PHASE2. Conditions: Hemophagocytic Lymphohistiocytoses
view source ↗
comments(0)
5-min edit window · permanent after that